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Introduction
In 2009, an estimated 5.6 million people were living with 
human immunodeficiency virus (HIV) in South Africa; more 
than in any other country in the world. The prevalence rate of 
HIV among 15- to 49-year-old people was estimated to be 
17.8%.1 The most common route of HIV transmission was 
heterosexual sex, followed by mother-to-child transmission, 
which can be as high as 30% without any intervention.2 
As a result of the high prevalence of HIV infection, the 
National Department of Health committed itself to providing 
antiretroviral therapy (ART) at public facilities to all patients 
with a CD4 count of 350 or less, and to those with World 
Health Organization stage 4 disease.2 Although South 
Africa has the most extensive ART programme in the world, 
access to treatment is still low. Only an estimated 10% of 
those needing treatment receive ART.3 
Just over 50% of those infected with HIV are women, the 
majority of whom are of reproductive age. Specific attention 
must be given to their contraceptive knowledge and practice. 
This is particularly important as effective contraception 
has been shown to reduce vertical transmission,4 and 
efavirenz is known to be teratogenic.5 Current first-line ART 
comprises two nucleoside reverse transcriptase inhibitors 
and one nonnucleoside reverse transcriptase inhibitor: 
either nevirapine or efavirenz.6 Nevirapine is hepatotoxic 
and can cause Stevens-Johnson syndrome. Efavirenz is 
generally preferred for paediatric patients, those on anti-
tuberculosis medication, male patients not working night 
shifts and female patients with no intention of having 
children.5 However, because of the teratogenic potential of 
efavirenz, women of reproductive age are usually started 
on nevirapine.5 Women who are on efavirenz for a variety 
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of reasons must be on reliable contraception to minimise 
the possibility of pregnancy and the risk of congenital 
malformations caused by efavirenz.7
According to the national guidelines, all patients must 
be counselled prior to the initiation of ART. Counselling 
must be given to women of childbearing age and should 
include contraceptive options, how HIV can be transmitted 
to the unborn child, and the dangers of falling pregnant 
while on efavirenz.8 Despite the need for comprehensive 
contraceptive counselling, condoms are often emphasised 
to the exclusion of other forms of contraception.8 Dual 
contraception is defined as the use of condoms plus the 
use of a short- or long-term reversible contraceptive or 
sterilisation. Condoms prevent transmission of HIV and other 
sexually transmitted infections (STIs). However, effective 
modern contraceptive use is important as condoms are 
very user-dependent. There is an up to 15% failure rate, 
depending upon user technique.9,10 HIV-positive women 
receiving ART should be on reliable dual contraception to 
enable them to plan a pregnancy, if so desired. Planning 
would allow time for the development of an undetectable 
viral load, a rising CD4 count (which reduces the chances 
of vertical transmission),11 and a switch to nevirapine-based 
regimens if necessary. 
Despite pre-initiation counselling, 22 000 HIV-positive 
women receiving ART fall pregnant each year in South 
Africa.5 No data are available to determine whether or 
not these pregnancies were planned. In 2009, a study 
undertaken in Zambia of 18 407 women at 16 ART clinics 
investigated contraceptive use,10 and in 2008, a study 
undertaken in South Africa assessed dual contraception 
use (condoms plus additional contraception) in areas of high 
prevalence in South Africa.12-15 These studies found that 
women with increased parity, women over 25 years of age 
and couples in short-term relationships, were more likely 
to use condoms than women with low levels of education 
and those in more stable or marital relationships. In 2006, a 
cohort study from rural Uganda of 733 HIV-positive women 
showed that a significant number of HIV-positive women on 
ART fell pregnant within 18 months of starting treatment.15 
Risk factors for falling pregnant identified in this study were 
a younger age, being married or living with a partner and 
inconsistent condom use.15        
In 2009, a significant number of women attending the 
Siyalulama ART clinic at a district hospital south of Durban 
were noted to have fallen pregnant after initiation of ART. 
The aim of this study was to determine the contraceptive 
knowledge and use of women attending this ART clinic in 
order to make recommendations about their reproductive 
health. 
Permission to conduct the study was given by the 
Biomedical Research and Ethics Committee of the University 
of KwaZulu-Natal, the KwaZulu-Natal Department of Health 
and the clinic management. The women who participated in 
the study gave their informed consent.
Method
This was an observational descriptive study carried out at 
an ART clinic south of Durban. Two thousand and fifty-six 
women of childbearing age attended this clinic in 2010. In 
consultation with a biostatistician, a sample of 400 women 
was selected (representing 20% of the study population). 
Women between the ages of 18 and 45 years, who had been 
receiving ART for a minimum of one month and who were 
willing to participate, were included in the study. Every third 
presenting woman at the clinic was selected to participate 
in the study until the required sample was reached. 
Participants were given information pamphlets and if they 
agreed to participate, were asked to sign a consent form.
Data were collected between October 2010 and June 2011 
by an HIV counsellor who completed the questionnaire with 
the patients. Patient charts were marked to ensure that the 
subjects only participated once. The questionnaire was 
adapted from knowledge, attitude, practice and behaviour 
studies in Nigeria, Uganda and South Africa.5,14-16 The 
questionnaire was validated in a pilot study on 10 patients 
attending the ART clinic at a neighbouring hospital. Minor 
modifications were made to the questionnaire after the 
pilot study. Data were entered into an SPSS® computer 
programme and analysed descriptively. 
Results
Ninety-six per cent of the patients were black and 4% were 
coloured. Seventy-three per cent were under the age of 35, 
with just over half between the ages of 25 and 35. Other 
important data are presented in Table I.
Contraceptive counselling was provided to all participants 
prior to initiation of ART with 95% (380/400) receiving 
counselling on the dangers of falling pregnant while 
receiving ART. Table II details the contraceptive knowledge 
and usage of participants.
Despite the excellent self-assessment, only 56% (224/400) 
of the women knew of three contraceptive methods, only 
47% (188/400) knew about emergency contraception, 
and only 11% (44/400) had used any form of emergency 
contraception. Over 90% of the women were sexually active 
and 34% reported at least one episode of unprotected sex 
in the last six months (Table III). Just over 50% (203/400) 
reported using dual contraception, of which the majority 
was condoms and an injectable form of contraception. Of 
those using male condoms, 60% preferred to buy products 
despite the fact that free condoms (Choice®) are distributed 
by the government. Of those using Choice®, 11% developed 
Original Research: Contraceptive knowledge and practice among HIV-positive women receiving antiretroviral therapy 
198 Vol 55 No 2S Afr Fam Pract 2013
a rash or itched after using it, 10% claimed that the condom 
burst easily, 10% didn’t trust it, 7% said that it smelt bad 
and 4% said that it didn’t feel good.
Eighty-two per cent (328/400) of participants reported 
having only one sexual partner. However, only 79% had 
disclosed their HIV status to their partner. Of the women 
whose partners used male condoms, 60% shared the 
responsibility with their partners for ensuring that a condom 
was available before intercourse, 28% took responsibility 
themselves for providing a condom, while 10% relied on 
their partners to do so. Thirty-four per cent of the study 
group indicated that their partners were resistant to condom 
use. Eight per cent said they were forced into unprotected 
sex when their partners were abusive or drunk, or insisted 
Table I: Baseline characteristics of human immunodeficiency virus-
positive women who participated in the study
Variable Number (%)
Age
18-24 years 75 (18.8%)
25-29 years 117 (29.3%)
30-34 years 106 (25.6%)
35-39 years 63 (15.8%)












> 1  188 (47%)








> 300 80 (20%)
< 300 < 300
Duration of ART
> 2 years 80 (20%)
< 2 years 320 (80%)
Currently on efavirenz-based ART regimen 
Yes 220 (55%)
No 180 (45%)
ART: antiretroviral therapy, CD4: cluster of differentiation 4 count, HIV: human 
immunodeficiency virus
Table II: Contraceptive counselling, knowledge and usage as reported 
by those who participated in the study
Variable Number (%)
Quality of contraceptive counselling received
Excellent 72 (18%)
Satisfactory 288 (74%)













Participants’ assessment of contraceptive knowledge 
Excellent 52 (13%)
Satisfactory 288 (74%)















No  32 (8%)
Episode of unprotected coitus in the last six months 
Yes 136 (34%)
No 264 (66%)
Sexually active in the last six months 
Yes 352 (88%)
No 48 (12%)
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on unprotected sex. Fourteen per cent of patients (56/400) 
had become pregnant while receiving ART. Three per cent 
had had two pregnancies while receiving ART, and 64% of 
the study group (256/400) planned to have a child within the 
next three years.
Discussion
The demographics of this study are in keeping with those of 
young, sexually active infected patients with HIV in South 
Africa. In 2009, national studies showed that almost one in 
three women in South Africa aged between 25 and 29 years 
lived with HIV.17 The majority of women in this study were 
single, young and unmarried. The 2003 National Strategic 
Plan identified single women aged between 15 and 25 
years as displaying the highest risk behaviour. They have 
a less than 25% chance of negotiating condom use when 
engaging in sexual activities.18 
Ninety-three per cent of the study population had received 
some schooling and 80% had a secondary school 
education. Numerous studies in southern Africa have 
shown that low education levels lead to decreased condom 
usage and decreased contraceptive compliance.5,9,11,12 The 
association between level of education and contraceptive 
use needs further study as in this study, there did not appear 
to be a correlation between the two. A large percentage of 
patients in this study had at least one child, suggesting that 
the prevention of mother-to-child transmission programme 
is effective in identifying HIV-positive pregnant women and 
referring them to treatment sites.
Contraceptive counselling and knowledge of barrier 
methods were reported to be excellent among the women 
who took part in this study. Ninety-five per cent of them 
had been counselled on the risks associated with having 
an unplanned pregnancy while receiving ART. However, it 
is of concern that barrier methods were the predominant 
and often sole method of contraception used. Only 53% of 
women used another form of contraception. 
The finding of low use of dual methods of contraception 
is consistent with the outcomes of a study carried out 
in Soweto, which showed that the importance of using 
condoms in preventing STIs and reinfection with HIV, as well 
as the need to use effective forms of contraception, was not 
clearly discussed with HIV-positive patients.19 However, this 
finding was better than the reported rate in Uganda, where 
only 18% of sexually active women receiving ART used dual 
methods of contraception.20 Further research is needed to 
assess the information that is provided to patients, barriers 
to the use of dual contraception methods and factors that 
influence the limited use of other contraceptive methods. 
The shortage of family planning services in South Africa, 
identified as a deficiency in primary healthcare services,12,14 
could be a reason for patients’ lack of knowledge about 
contraceptive options. It is important for healthcare workers 
to counsel patients whenever they visit the ART site, and 
to address any deficiencies in patients’ contraceptive 
knowledge and willingness to use dual contraception 
methods.12
There is no doubt that condoms are the most common form 
of contraception available in South Africa.18 Two hundred 
and fifty-six million condoms were freely distributed by 
the government in 2007. Condoms have the advantage of 
preventing transmission of STIs. Despite 3.5-million female 
condoms being distributed between 2006 and 2007,18 only 
56% of the women in this study had received education on 
them and only 2% had ever used one. This is lower than 
that reported in other sub-Saharan countries.20 In 2005, 
a study in Zimbabwe which assessed female condom 
usage, reported that less than 10% of women had ever 
used a female condom.20 Female condoms are as safe as 
male condoms in protecting against STIs and HIV,21 and 
have the added advantage of giving women the power to 
protect themselves, rather than relying on men to provide 
the contraception. This is important as 35% of participants 
indicated that their partners would not always use condoms. 
A study in Cape Town which examined the reproductive 
needs and choices of men and women living with HIV 
concluded that everyone needed to be empowered to make 
informed choices about his or her own reproductive needs.5
In keeping with other studies that have been carried out in 
South and other African countries,15 this study reaffirmed 
that HIV-positive women receiving ART are sexually 
active. This is unsurprising as ART restores health and 
fertility, and as women’s health improves, they resume 
socially productive and sexually active lives.15 This finding 
reinforces the need to provide appropriate advice on dual 
contraception to women on ART. It is of concern that despite 
sufficient knowledge about condoms, 31% (124/400) of 
participants admitted to having unprotected sex in the last 
six months. This finding is consistent with those from other 
studies in Africa which showed that the rate of unprotected 
sex among women having sex with a regular partner varied 
between 26 and 59%.6,9 Trust was identified as one of the 
major factors for not using condoms.11 Women in long-term 
relationships were less likely to use a condom than those 
in short-term ones. It was of concern that only 79% of 
women had disclosed their HIV status to their partners. This 
highlights some of the challenges that women face when 
discussing sensitive issues with their partners. 
Current recommendations by the National Department of 
Health are that HIV-positive couples should always use a 
condom to prevent the possibility of acquiring another STI 
or a drug-resistant strain of HIV, as well as utilise a reliable 
form of contraception.18 Identified factors which contribute 
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to condoms not being used include the unplanned nature 
of sexual encounters, the desire to have children and not 
wanting to be identified as being infected with HIV.13,15 A 
study that was carried out in South Africa at two ART sites 
on 369 patients showed that with proper education and 
family planning workshops, dual contraception use in HIV-
positive women receiving ART improved from a baseline of 
10% to 30-50%.22 A study that was conducted in Lusaka 
demonstrated that when family planning services were 
integrated into care that was offered at the ART site, the rate 
of dual contraception improved by 33%.14 However, when 
family planning was provided outside the ART site, there 
was a drop of 15% in non-barrier contraceptive use over 
a one-year period.14 In the current study, 14% of patients 
had already fallen pregnant while on ART, and 64% of the 
patients indicated that they planned to have a child in the 
future. Healthcare providers working at ART sites need to 
be alert to this and must discuss contraceptive options, 
possible ART regimen change, as well as readiness to have 
children, with women of childbearing age on a regular basis. 
Conclusion and recommendations 
This study has demonstrated that most HIV-positive women 
are sexually active and are well informed about condom use 
and hormonal forms of contraception (oral and injectable). 
However, the majority of these women rely on male 
condom use for protection against STIs and the prevention 
of pregnancy. Just over half of the women used modern 
hormonal contraceptive methods. 
Recommendations from this study include integration 
of HIV and family planning services to improve dual 
contraception use, as well as routinely making enquiries 
about contraceptive usage and a women’s desire to have 
a child. Ongoing education must be provided on pregnancy 
and the risks of mother-to-child transmission of HIV to the 
unborn child. Female condoms need to be readily available 
and their use popularised. Further research is required to 
assess barriers to the use of female condoms and dual 
contraception use.
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